Amy Coney Barrett Faces Conservative Backlash After Key Supreme Court Rulings Against Trump 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Trump Threatens ABC News Lawsuit Over Lincoln Memorial Reflecting Pool Coverage 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
DOJ Seeks Dismissal of Fraud Charges Against Gautam Adani in U.S. Court 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
US Supreme Court Strikes Down Hawaii Gun Carry Law on Private Property 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
US Appeals Court Limits ICE Detention Without Bond Hearings After 90 Days 
California Court Dismisses Trump Administration Lawsuit Against Los Angeles Sanctuary Policy 
On Monday, a U.S. appeals court ruled in favor of 3M, E.I. du Pont de Nemours and Co, and other manufacturers of "forever chemicals." The court rejected a lower court's ruling, allowing approximately 11.8 million Ohio residents to sue the companies.
Reuters noted that the ruling relieves considerable legal pressure placed on the chemical manufacturers to settle the plaintiffs' claims.
Court Ruling Questions Class Action Suit's Validity
According to Yahoo, Lead plaintiff Kevin Hardwick's complaint against the manufacturers faced scrutiny from the court. The appeals court found his complaint to be overly broad and lacking evidence that the per- and polyfluoroalkyl substances (PFAS) detected in his body could be directly attributed to the defendants.
The court emphasized that the complaint targeted the collective actions of the companies rather than individual responsibility. Notably, the case involved just 10 out of thousands of companies involved in PFAS manufacturing.
The lower court's approval of the class action suit has been vacated, and the court instructed the dismissal of Hardwick's lawsuit. The lawsuit aimed to hold the companies accountable for the health impacts of PFAS exposure and sought to establish a fund to monitor Ohio residents.
Additionally, Hardwick's request for the companies to fund studies on the health effects of PFAS was denied. These forever chemicals, commonly found in consumer products, have been linked to cancer and other diseases.
Robert Bilott, attorney for Hardwick, expressed disappointment with the court's decision. He stated that it contradicts what is known about the history of PFAS manufacturing in the United States. Bilott's legal team is currently evaluating whether to appeal the ruling further.
The Persistence and Prevalence of Forever Chemicals
PFAS substances earned the nickname "forever chemicals" due to their resistance to breaking down in nature or in the human body. The growing number of lawsuits filed against 3M, DuPont, and other manufacturers in recent years reflect concerns over alleged PFAS contamination.
In June, 3M agreed to pay $10.3 billion to settle hundreds of claims regarding public drinking water pollution caused by PFAS. Furthermore, Chemours Co, DuPont de Nemours Inc, and Corteva reached a similar settlement worth $1.19 billion with U.S. water providers.
Photo: 3M News Center
